About Adaptive biotechnologies corp.
Adaptive Biotechnologies Corp. is a leading biotechnology company that is revolutionizing the field of medicine by harnessing the power of the immune system. The company's mission is to develop innovative diagnostic and therapeutic solutions that can help patients fight diseases more effectively.
Founded in 2009, Adaptive Biotechnologies has quickly become a leader in the field of immunology. The company's proprietary technology platform, called immunoSEQ, allows researchers to analyze the genetic makeup of immune cells with unprecedented accuracy and speed. This technology has already been used to identify new biomarkers for cancer and other diseases, paving the way for more personalized treatments.
One of Adaptive Biotechnologies' most exciting projects is its partnership with Microsoft on a project called ImmuneCode. This project aims to create a "map" of the human immune system using machine learning algorithms and big data analysis. By understanding how different immune cells interact with each other and with pathogens, scientists hope to develop new therapies that can boost immunity or target specific disease-causing agents.
Another area where Adaptive Biotechnologies is making significant strides is in developing diagnostic tests for infectious diseases like COVID-19. The company's T-Detect test uses immunoSEQ technology to detect T-cells that have been activated by SARS-CoV-2, providing an accurate diagnosis even in cases where traditional PCR tests may produce false negatives.
In addition to its groundbreaking research efforts, Adaptive Biotechnologies also offers a range of products and services for researchers and clinicians working in immunology. These include custom sequencing services, software tools for data analysis, and reagents for cell isolation and characterization.
Overall, Adaptive Biotechnologies Corp. represents an exciting new frontier in medical research and innovation. By leveraging cutting-edge technologies like machine learning and genomics, this company is poised to make significant contributions towards improving human health around the world.